Market cap
$115 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -31.26 | 676.76 | -- |
| EBIT | 77.16 | 48.26 | 39.35 | 1.39 | -249.38 |
| Net Profit | 17.61 | 55.86 | -7.02 | 2.00 | -248.40 |
| EPS | 17.61 | 55.89 | -6.96 | 6.54 | -229.84 |
| Book Value | -- | -- | -49.14 | -34.89 | -12.81 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | 4,445,555.56 | -10,115.71 | -- | -- |
| Net Margin
| -- | -6,584.27 | -9,273.93 | -- | -- |
| Return on equity
| -51.04 | -40.32 | -104.07 | -82.66 | -17.19 |
| Return on Capital
| -51.03 | -40.31 | -- | -82.66 | -17.19 |
| Return on Assets
| -44.00 | -35.70 | -44.45 | -65.95 | -15.75 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | -- |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
-82.66
|
-17.19
|
-53.25
|
-30.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-104.07
Lower than Peers by 63.78
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-104.07
|
-82.66
|
-17.19
|
-53.27
|
-30.11
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-44.45
Lower than Peers by 13.62
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-44.45
|
-65.95
|
-15.75
|
-50.31
|
-28.90
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
-10,115.71
Lower than Peers by 10,033.50
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-10,115.71
|
--
|
--
|
--
|
4,445,555.56
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
-9,273.93
Lower than Peers by 9,184.05
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-9,273.93
|
--
|
--
|
--
|
4,026,222.22
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
Lower than Peers by 0.01
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-31.26
Lower than Peers by 85.29
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-31.26
|
--
|
--
|
1.00
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
39.35
Higher than Peers by 40.30
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
39.35
|
32.96
|
-34.28
|
-32.41
|
-143.46
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
-7.02
Higher than Peers by 0.16
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-7.02
|
-273.73
|
74.96
|
-34.14
|
-127.89
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
-6.96
Lower than Peers by 21.39
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-6.96
|
-2.72
|
0.78
|
-0.30
|
-1.23
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
-46.64
Lower than Peers by 36.18
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
-46.64
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
--
|
--
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
--
|
--
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.19
Lower than Peers by 3.61
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
2.19
|
2.23
|
11.62
|
9.13
|
29.91
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
2.19
Lower than Peers by 3.50
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
2.19
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
--
|
--
|
--
|
-21.20
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
13.93
Lower than Peers by 5.05
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
13.93
|
--
|
--
|
--
|
--
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
0.00
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
0.00
|
--
|
--
|
--
|
0.00
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
9,619.23
|
2,940.55
|
29.80
|
1,564.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
-1.05
|
-4.66
|
-9.77
|
-16.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.92
Lower than Peers by 4.43
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
0.92
|
1.29
|
0.78
|
6.91
|
5.29
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
2.08
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
2.08
|
0.00
|
0.11
|
-7.93
|
-12.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
115
Lower than Peers by 32
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Cassava Sciences (SAVA)
|
115
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|